Frost & Sullivan to Moderate International Conference at MEDICA 2007

Frost & SullivanHosted by the U.S. Government in partnership with Frost & Sullivan and several strategic partners, the International Conference at MEDICA 2007 is expected to see attendance by every international medical device, equipment and diagnostic company. This pioneering event offers the international medical technology community a unique opportunity to tap the expertise and resources needed to be successful on the world's most important medical market - the USA.

Dorman Followwill, Vice President, Health Care, Frost & Sullivan, who will moderate the conference, notes that this event comes at a time when international medical technology firms, facing strong cost containment pressures, slower growth and challenging regulatory environments, are looking to the U.S. as a rewarding market for innovative products.

"Clearly, the U.S. market offers medical device companies several global competitive advantages," says Followwill. "However, it is essential for international firms to implement the correct strategy on local engagement in the highly competitive U.S. market where volatile currency fluctuations, heightened scrutiny on import safety issues, complex reimbursement systems and regional/local market preferences and practices, all demand careful consideration."

Through this conference, participants will be privy to crucial information and insights aimed at helping international medtech companies establish a presence or expand in the United States. Experts from the U.S. Department of Commerce, its U.S. federal state partners, the U.S. Food and Drug Administration, along with leading industry association officials, company heads and prominent legal, financial and business advisors in the health technology sector will make presentations, participate in panel discussions.

Besides in-depth and insightful information, the forum offers attractive networking opportunities. Attendees can profit from personal consultations with expert speakers and U.S. state representatives during breaks, the relaxed networking reception and in follow on meetings.

In short, anyone responsible for a medical company's global success will find invaluable guidance and networking opportunities on November 13th at the Hilton Hotel, Düsseldorf.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...